APHB - AmpliPhi Biosciences Corporation

NYSE American - NYSE American Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue-115260475
Cost of Revenue4,8922,8815,6783,992
Gross Profit-4,892-2,766-5,418-3,517
Operating Expenses
Research Development----
Selling General and Administrative-7,0908,4136,710
Non Recurring----
Total Operating Expenses-9,97114,09110,702
Operating Income or Loss--9,856-13,831-10,227
Income from Continuing Operations
Total Other Income/Expenses Net--4,284-5,5639,638
Earnings Before Interest and Taxes--9,856-13,831-10,227
Interest Expense----
Income Before Tax--14,140-19,394-589
Income Tax Expense--1,302-556-73
Minority Interest----
Net Income From Continuing Ops--12,838-18,838-516
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income--12,838-18,838-516
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares--12,838-24,276-10,794